Health News

Antibody combo prevents infection from SARS-CoV-2 exposure

(HealthDay)—For household contacts of infected persons, subcutaneous REGEN-COV, a combination of the monoclonal antibodies casirivimab and imdevimab, prevents symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online Aug. 4 in the New England Journal of Medicine. Meagan P. O’Brien, M.D., from Regeneron Pharmaceuticals in Tarrytown, New York, […]